SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer:
SEC Accession No. 0000882104-21-000009
Filing Date
2021-01-15
Accepted
2021-01-15 17:23:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-I a20210115todoc.htm SC TO-I 33443
2 EX-1.A exhibita1.htm EX-1.A 193176
  Complete submission text file 0000882104-21-000009.txt   228455
Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Filed by) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521
Business Address 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO NV 89521 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I | Act: 34 | File No.: 005-43256 | Film No.: 21533111
SIC: 2836 Biological Products, (No Diagnostic Substances)